Cover Image
市場調查報告書

糖尿病護理設備的金磚四國市場預測 ∼2020年:血糖值自我測量儀、持續型血糖監測儀、試驗帶、採血針、胰島素幫浦、胰島素筆針、胰島素注射器

Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC) by Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes) - Forecast to 2020

出版商 MarketsandMarkets 商品編碼 338556
出版日期 內容資訊 英文 109 Pages
訂單完成後即時交付
價格
Back to Top
糖尿病護理設備的金磚四國市場預測 ∼2020年:血糖值自我測量儀、持續型血糖監測儀、試驗帶、採血針、胰島素幫浦、胰島素筆針、胰島素注射器 Diabetes Care Devices Market In Brazil, Russia, India & China (BRIC) by Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes) - Forecast to 2020
出版日期: 2015年08月26日 內容資訊: 英文 109 Pages
簡介

金磚四國的糖尿病護理設備的市場近幾年急劇成長,在預測期間內也以6.3%的年複合成長率成長。預計今後的市場成長,受到糖尿病人口的增加和糖尿病管理的照護設備的擴大引進,患者、醫生的糖尿病管理複雜等推動。預計2014年的市場佔有率上中國記錄著最大的佔有率,在預測期間內的成長率上印度記錄最大的成長率。

本報告提供全球糖尿病護理設備的市場相關調查、主要的產業趨勢與技術的進步、各國市場促進因素、阻礙要素、市場機會、市場課題、各產品類型的市場規模的變化與預測、主要企業的市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 成長的潛在性
  • 金磚四國的血糖監測系統設備市場
  • 糖尿病護理設備市場:各地區
  • 中國:在預測期間內的主要市場
  • 金磚四國的糖尿病護理設備市場

第5章 產業分析

  • 趨勢
    • 印度的糖尿病護理市場成長
    • 持續的血糖監測系統的轉變
    • 非侵入性血糖值計的開發
  • 胰島素給藥系統的技術進步
    • 胰島素吸入器
    • 胰島素口服藥
    • 人工胰臟
    • 胰島素貼片/經皮胰島素給藥

第6章 巴西:糖尿病護理設備市場

  • 簡介
  • 市場促進因素
  • 市場成長的阻礙要素
  • 市場機會
  • 市場課題
  • 市場規模
  • 市場佔有率

第7章 俄羅斯:糖尿病護理設備市場

  • 簡介
  • 市場促進因素
  • 市場成長的阻礙要素
  • 市場機會
  • 市場課題
  • 市場規模
  • 市場佔有率

第8章 印度:糖尿病護理設備市場

  • 簡介
  • 市場促進因素
  • 市場成長的阻礙要素
  • 市場機會
  • 市場課題
  • 市場規模
  • 市場佔有率

第9章 中國:糖尿病護理設備市場

  • 簡介
  • 市場促進因素
  • 市場成長的阻礙要素
  • 市場機會
  • 市場課題
  • 市場規模
  • 市場佔有率

第10章 競爭環境

  • 競爭情形、趨勢
    • 擴張
    • 協定、聯盟、合作
    • 新產品的投入

第11章 企業簡介

  • ROCHE DIAGNOSTICS LIMITED
  • JOHNSON & JOHNSON
  • ABBOTT LABORATORIES
  • BAYER AG
  • MEDTRONIC PLC
  • BECTON, DICKINSON AND COMPANY
  • YPSOMED AG
  • NOVO NORDISK A/S
  • ARKRAY, INC.
  • SANOFI
  • ACON LABORATORIES, INC.
  • Terumo Corporation
  • DEXCOM, INC.
    • 產業概要
    • 產品與服務
    • 分析
    • 戒煙的發展趨勢
    • MNM的見解等

第12章 附錄

圖表

目錄
Product Code: MD 3684

Diabetes is a group of metabolic disorders, characterized by high blood glucose levels due to either inadequate insulin production or insulin resistance. Diabetes care devices are used to manage blood glucose levels. There are mainly two types of diabetes care devices, namely, blood glucose monitoring devices and insulin delivery devices. The BRIC diabetes care devices market is largely driven by the increasing number of diabetics across BRIC countries, growing research on diabetes, and increasing international research collaborations. The rising obese population and rapid industrialization and urbanization are further expected to contribute to the growth of this market. However, high cost of diabetes care devices, disparity in reimbursement, availability of alternative treatments, and lack of awareness inhibit the growth of this market.

In this report, the BRIC diabetes care devices market has been segmented by type into blood glucose monitoring devices and insulin delivery devices. The blood glucose monitoring devices segment is further classified into testing strips, self-monitoring blood glucose meters, lancets, continuous glucose monitors, and others; while, the insulin drug delivery devices segment is subsegmented into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors.

The BRIC diabetes care devices market has witnessed strong growth in the past few years, and is further expected to grow at an approximate CAGR of 6.3% during the forecast period. Rising diabetic population in BRIC countries and growing adoption of diabetes care devices for management of diabetes and its complications by patients and healthcare professionals will propel the growth of the BRIC diabetes care devices market. China accounted for the largest share of this market in 2014; while, India is expected to witness the highest growth rate during the forecast period.

Some of the major players in this market include Becton, Dickinson and Company (U.S.), Roche Diagnostics Ltd. (Switzerland), Johnson and Johnson (U.S.), Bayer AG (Germany), Abbott Laboratories (U.S.), Acon Laboratories, Inc. (U.S.), Ypsomed AG (Switzerland), Novo Nordisk A/S (Denmark), Medtronic plc (Ireland), ARKRAY Inc. (Japan), Terumo Corporation (Japan), Dexcom, Inc. (U.S.), and Sanofi (France).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms, and allow them to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use one or a combination of the below-mentioned strategies (market penetration, product development/innovation, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the BRIC diabetes care devices market. The report analyzes the BRIC diabetes care devices market by type and country
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the BRIC diabetes care devices market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, and manufacturing capabilities of the leading players in the BRIC diabetes care devices market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. PRODUCT DESCRIPTION
      • 1.3.2.1. Blood glucose monitoring devices
        • 1.3.2.1.1. Self-monitoring blood glucose meters
        • 1.3.2.1.2. Continuous glucose monitors (CGM)
        • 1.3.2.1.3. Testing strips
        • 1.3.2.1.4. Lancets
        • 1.3.2.1.5. Other blood glucose monitoring devices
      • 1.3.2.2. Insulin delivery devices
        • 1.3.2.2.1. Insulin pumps
        • 1.3.2.2.2. Insulin pens
        • 1.3.2.2.3. Insulin syringes
        • 1.3.2.2.4. Insulin jet injectors
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
    • 2.4.1. KEY DATA FROM SECONDARY SOURCES
    • 2.4.2. KEY DATA FROM PRIMARY SOURCES
      • 2.4.2.1. Key Industry Insights
  • 2.5. ASSUMPTIONS
    • 2.5.1. MARKET ASSUMPTIONS
    • 2.5.2. PRICE ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GROWTH POTENTIAL OF THE BRIC DIABETES CARE DEVICES MARKET
  • 4.2. BRIC BLOOD GLUCOSE MONITORING DEVICES MARKET
  • 4.3. DIABETES CARE DEVICES MARKET, BY GEOGRAPHY
  • 4.4. CHINA TO DOMINATE THE DIABETES CARE DEVICES MARKET DURING THE FORECAST PERIOD
  • 4.5. BRIC DIABETES CARE DEVICES MARKET

5. INDUSTRY INSIGHTS

  • 5.1. TRENDS
    • 5.1.1. GROWING DIABETES CARE MARKET IN INDIA
    • 5.1.2. SHIFT TOWARDS CONTINUOUS GLUCOSE MONITORS
    • 5.1.3. DEVELOPMENT OF NONINVASIVE GLUCOMETERS
  • 5.2. TECHNOLOGICAL ADVANCEMENTS IN INSULIN DELIVERY SYSTEMS
    • 5.2.1. INSULIN INHALERS
    • 5.2.2. ORAL INSULIN
    • 5.2.3. ARTIFICIAL PANCREAS
    • 5.2.4. INSULIN PATCHES/TRANSDERMAL INSULIN DELIVERY

6. BRAZIL: DIABETES CARE DEVICES MARKET

  • 6.1. INTRODUCTION
  • 6.2. MARKET DRIVERS
    • 6.2.1. INCREASING INCIDENCE OF DIABETES ESPECIALLY AMONG OBESE POPULATION
    • 6.2.2. INCREASED COLLABORATIONS AND FUNDING TO SUPPORT DIABETES RESEARCH
  • 6.3. MARKET RESTRAINTS
    • 6.3.1. LACK OF AWARENESS
    • 6.3.2. GEOGRAPHICAL LIMITATIONS
  • 6.4. MARKET OPPORTUNITIES
    • 6.4.1. FAVORABLE GOVERNMENT POLICIES
  • 6.5. MARKET CHALLENGES
    • 6.5.1. STRINGENT REGULATIONS AND REGISTRATION PROCESS
  • 6.6. MARKET SIZE
  • 6.7. MARKET SHARE

7. RUSSIA: DIABETES CARE DEVICES MARKET

  • 7.1. INTRODUCTION
  • 7.2. MARKET DRIVERS
    • 7.2.1. GROWTH IN AGING POPULATION
    • 7.2.2. LARGE URBAN POPULATION AND RISING OBESITY
    • 7.2.3. GROWING FOCUS OF MARKET PLAYERS TOWARDS RUSSIA
  • 7.3. MARKET RESTRAINTS
    • 7.3.1. HIGH COST OF DIABETES CARE DEVICES
    • 7.3.2. DISPARITY IN REIMBURSEMENT
    • 7.3.3. LARGE POOL OF UNDIAGNOSED PATIENTS
  • 7.4. MARKET OPPORTUNITIES
    • 7.4.1. GROWING AWARENESS ABOUT DIABETES
  • 7.5. MARKET CHALLENGES
    • 7.5.1. SHORTAGE OF HEALTHCARE PROFESSIONALS IN DIABETES MANAGEMENT
  • 7.6. MARKET SIZE
  • 7.7. MARKET SHARE

8. INDIA: DIABETES CARE DEVICES MARKET

  • 8.1. INTRODUCTION
  • 8.2. MARKET DRIVERS
    • 8.2.1. INCREASING DIABETIC POPULATION
    • 8.2.2. LIFE STYLE CHANGES DRIVING PREVALENCE OF DIABETES AMONG URBAN POPULATION
    • 8.2.3. GROWING RESEARCH ON DIABETES AND ITS MANAGEMENT
  • 8.3. MARKET RESTRAINTS
    • 8.3.1. HIGH COST OF TREATMENT AND DEVICES
    • 8.3.2. EMERGING ALTERNATIVE THERAPIES
    • 8.3.3. LACK OF AWARENESS
  • 8.4. MARKET OPPORTUNITIES
    • 8.4.1. HUGE UNTAPPED MARKET POTENTIAL FOR DIABETES CARE DEVICES
  • 8.5. MARKET CHALLENGES
    • 8.5.1. PRICING PRESSURE FACED BY GLOBAL PLAYERS
  • 8.6. MARKET SIZE
  • 8.7. MARKET SHARE

9. CHINA: DIABETES CARE DEVICES MARKET

  • 9.1. INTRODUCTION
  • 9.2. MARKET DRIVERS
    • 9.2.1. RISING DIABETIC POPULATION
    • 9.2.2. INCREASING NUMBER OF INTERNATIONAL RESEARCH COLLABORATIONS
    • 9.2.3. EXPANSION OF GLOBAL PLAYERS AND GROWING GOVERNMENT INITIATIVES
  • 9.3. MARKET RESTRAINTS
    • 9.3.1. HIGH COST OF TREATMENT AND DEVICES
    • 9.3.2. TRADITIONAL CHINESE MEDICINE AS AN ALTERNATIVE
    • 9.3.3. LOW REIMBURSEMENT FOR DIABETES CARE DEVICES
  • 9.4. MARKET OPPORTUNITIES
    • 9.4.1. IMPROVED PRIMARY CARE STRUCTURE
  • 9.5. MARKET CHALLENGES
    • 9.5.1. NONADHERENCE TO INTERNATIONAL STANDARDS AND GMPS BY LOCAL MANUFACTURERS
    • 9.5.2. REGULATORY SCENARIO
  • 9.6. MARKET SIZE
  • 9.7. MARKET SHARE

10. COMPETITIVE LANDSCAPE

  • 10.1. COMPETITIVE SITUATION AND TRENDS
    • 10.1.1. EXPANSIONS
    • 10.1.2. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 10.1.3. NEW PRODUCT LAUNCHES

11. COMPANY PROFILES (Business Overview, Products & Services, Key Insights, Recent Developments, MnM View)*

  • 11.1. ROCHE DIAGNOSTICS LIMITED
  • 11.2. JOHNSON & JOHNSON
  • 11.3. ABBOTT LABORATORIES
  • 11.4. BAYER AG
  • 11.5. MEDTRONIC PLC
  • 11.6. BECTON, DICKINSON AND COMPANY
  • 11.7. YPSOMED AG
  • 11.8. NOVO NORDISK A/S
  • 11.9. ARKRAY, INC.
  • 11.10. SANOFI
  • 11.11. ACON LABORATORIES, INC.
  • 11.12. TERUMO CORPORATION
  • 11.13. DEXCOM, INC.

*Details on Business Overview, Products & Services, Key Insights, Recent Developments, MnM View might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. AVAILABLE CUSTOMIZATIONS
  • 12.4. INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
  • 12.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: BRAZIL: AVERAGE SELLING PRICE OF DIABETES CARE DEVICES (USD/UNIT)
  • TABLE 2: RUSSIA: AVERAGE SELLING PRICE OF DIABETES CARE DEVICES (USD/UNIT)
  • TABLE 3: INDIA: AVERAGE SELLING PRICE OF DIABETES CARE DEVICES (USD/UNIT)
  • TABLE 4: CHINA: AVERAGE SELLING PRICE OF DIABETES CARE DEVICES (USD/UNIT)
  • TABLE 5: BRIC BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT, 2014 (USD MILLION)
  • TABLE 6: BRIC INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2014 (USD MILLION)
  • TABLE 7: MARKET SHARES OF PLAYERS, 2014
  • TABLE 8: LIST OF SOME NONINVASIVE GLUCOSE METERS
  • TABLE 9: BRAZIL: DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 10: BRAZIL: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 11: BRAZIL: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (THOUSAND UNITS)
  • TABLE 12: BRAZIL: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 13: BRAZIL: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (THOUSAND UNITS)
  • TABLE 14: RUSSIA: DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 15: RUSSIA: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 16: RUSSIA : BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (THOUSAND UNITS)
  • TABLE 17: RUSSIA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 18: RUSSIA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (THOUSAND UNITS)
  • TABLE 19: INDIA: DIABETES STATISTICS (2009-2013)
  • TABLE 20: INDIA: DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 21: INDIA: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 22: INDIA: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (THOUSAND UNITS)
  • TABLE 23: INDIA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 24: INDIA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (THOUSAND UNITS)
  • TABLE 25: CHINA: DIABETES STATISTICS (2009-2013)
  • TABLE 26: CHINA: DIABETES CARE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 27: CHINA: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 28: CHINA: BLOOD GLUCOSE MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (THOUSAND UNITS)
  • TABLE 29: CHINA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (USD MILLION)
  • TABLE 30: CHINA: INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2013-2020 (THOUSAND UNITS)
  • TABLE 31: EXPANSIONS, 2012-2015
  • TABLE 32: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012-2015
  • TABLE 33: NEW PRODUCT LAUNCHES, 2012-2015

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: DIABETIC POPULATION SIZE, 2013 AND 2035: GLOBAL VS. BRIC
  • FIGURE 7: TESTING STRIPS HOLD LARGEST SHARE OF BLOOD GLUCOSE MONITORING DEVICES MARKET
  • FIGURE 8: INSULIN PENS DOMINATE INSULIN DELIVERY DEVICES MARKET
  • FIGURE 9: RISE IN DIABETIC POPULATION, INCREASING OBESITY TO DRIVE MARKET GROWTH
  • FIGURE 10: CHINA ACCOUNTED FOR THE LARGEST SHARE OF THE BRIC BLOOD GLUCOSE MONITORING DEVICES MARKET
  • FIGURE 11: CHINA ACCOUNTED FOR ABOUT HALF OF THE BRIC DIABETES CARE DEVICES MARKET IN 2014
  • FIGURE 12: DIABETES CARE DEVICES MARKET: GEOGRAPHIC MIX
  • FIGURE 13: INDIA TO REGISTER HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 14: GROWING DIABETES CARE MARKET IN INDIA AND SHIFT TOWARDS CONTINUOUS GLUCOSE MONITORS
  • FIGURE 15: BLOOD GLUCOSE MONITORING DEVICES MARKET, BY TYPE, 2015 VS. 2020
  • FIGURE 16: BRAZIL: DIABETES CARE DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 17: RUSSIA: AGING POPULATION STATISTICS (2011-2050)
  • FIGURE 18: LOW DIABETES DIAGNOSIS RATE: A MAJOR CONCERN IN RUSSIA
  • FIGURE 19: RUSSIA: DIABETES CARE DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 20: CONTINUOUS GLUCOSE MONITORS ARE EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 21: INDIA DIABETES CARE DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 22: CHINA ACCOUNTED FOR NEARLY 1/4TH OF THE GLOBAL DIABETIC POPULATION IN 2013
  • FIGURE 23: INSULIN PUMPS MARKET TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 24: CHINA: DIABETES CARE DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 25: COMPANIES ADOPTED EXPANSIONS AND AGREEMENTS AS THEIR KEY GROWTH STRATEGIES (2012-2015)
  • FIGURE 26: BATTLE FOR MARKET SHARE: EXPANSIONS WAS THE KEY STRATEGY
  • FIGURE 27: ROCHE DIAGNOSTICS LIMITED: COMPANY SNAPSHOT
  • FIGURE 28: JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • FIGURE 29: ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 30: BAYER AG: COMPANY SNAPSHOT
  • FIGURE 31: MEDTRONIC PLC: COMPANY SNAPSHOT
  • FIGURE 32: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 33: YPSOMED AG: COMPANY SNAPSHOT
  • FIGURE 34: NOVO NORDISK A/S: COMPANY SNAPSHOT
  • FIGURE 35: SANOFI: COMPANY SNAPSHOT
  • FIGURE 36: TERUMO CORPORATION: COMPANY SNAPSHOT
  • FIGURE 37: DEXCOM, INC.: COMPANY SNAPSHOT
Back to Top